Diagnostic accuracy of the Cepheid GeneXpert vanA/vanB assay ver. 1.0 to detect the vanA and vanB vancomycin resistance genes in Enterococcus from perianal specimens

Diagnostic Microbiology and Infectious Disease

Volumn 69, Issue 4, 2011, Pages 382-389

  Marner, Erin S ^a   Wolk, Donna M ^a,b   Carr, Jeanne ^d   Hewitt, Carolyn ^d   Dominguez, Lorraine L ^c   Kovacs, Thomas ^c   Johnson, Desiree R ^a,b   Hayden, Randall T ^d  

^a UNIVERSITY OF ARIZONA   (United States)

^b BIO5 Institute   (United States)

^c UNIVERSITY OF ARIZONA MEDICAL CENTER   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Culture; GeneXpert; Real time PCR; VRE

Indexed keywords

VANCOMYCIN;

ANALYTIC METHOD; ANUS; ARTICLE; ASSAY; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; COLONY FORMING UNIT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENTEROCOCCUS; ENTEROCOCCUS AVIUM; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS DURANS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; ENTEROCOCCUS HIRAE; INTERMETHOD COMPARISON; MICROBIAL DIVERSITY; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STANDARD; VANA GENE; VANB GENE;

ANAL CANAL; BACTERIAL PROTEINS; BACTERIOLOGICAL TECHNIQUES; CARBON-OXYGEN LIGASES; CELL CULTURE TECHNIQUES; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 79952407235     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.11.005     Document Type: Article

References (44)

1. Al-Mohri H.A., Tadros M.A., Louie L., Vearncombe M., Simor A.E. Utility of direct, real-time PCR in the management of a nosocomial outbreak of vancomycin-resistant Enterococcus faecium (vanB genotype). Eur. J. Clin. Microbiol. Infect. Dis. 2008, 27:321-322.
2. Ballard S.A., Pertile K.K., Lim M., Johnson P.D., Grayson M.L. Molecular characterization of vanB elements in naturally occurring gut anaerobes. Antimicrob. Agents Chemother. 2005, 49:1688-1694.
3. Bourdon N., Berenger R., Lepoultier R., Mouet A., Lesteven C., Borgey F., Fines-Guyon M., Leclercq R., Cattoir V. Rapid detection of vancomycin-resistant enterococci from rectal swabs by the Cepheid Xpert vanA/vanB assay. Diagn. Microbiol. Infect. Dis. 2010, 67:291-293.
4. Boyce J.M., Opal S.M., Chow J.W., Zervos M.J., Potter-Bynoe G., Sherman C.B., Romulo R.L., Fortna S., Medeiros A.A. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J. Clin. Microbiol. 1994, 32:1148-1153.
5. Calderwood M.S., Mauer A., Tolentino J., Flores E., van Besien K., Pursell K., Weber S.G. Epidemiology of vancomycin-resistant enterococci among patients on an adult stem cell transplant unit: observations from an active surveillance program. Infect. Control Hosp. Epidemiol. 2008, 29:1019-1025.
6. Cetinkaya Y., Falk P., Mayhall C.G. Vancomycin-resistant enterococci. Clin. Microbiol. Rev. 2000, 13:686-707.
7. Clinical and Laboratory Standards Institute (CLSI) User protocol for evaluation of qualitative test performance. Approved Guidelines ed. NCCLS Document EP12-A 2000, CLSI, Wayne, PA.
8. Clinical and Laboratory Standards Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-seventh edition, M7-A7 (2006) & performance standards for antimicrobial susceptibility testing; seventeenth informational supplement and MS100-S17 (2007). Approved Guidelines ed. CLSI Document M7-A7 (2006) and MS100-S17 (2007) 2007, CLSI, Wayne, PA.
9. Courvalin P. Vancomycin resistance in gram-positive cocci. Clin. Infect. Dis. 2006, 42(Suppl 1):S25-S34.
10. Department of Health and Human Services Protection of human research subjects. Final rule. Fed. Regist. 2001, 66:56775-56780.
11. Department of Health and Human Services Standards for privacy of individually identifiable health information, final rule. Fed. Regist. 2002, 67:53181-53273.
12. Diekema D.J., Edmond M.B. Look before you leap: active surveillance for multidrug-resistant organisms. Clin. Infect. Dis. 2007, 44:1101-1107.
13. Donskey C.J., Schreiber J.R., Jacobs M.R., Shekar R., Salata R.A., Gordon S., Whalen C.C., Smith F., Rice L.B. A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in northeast Ohio. Northeast Ohio Vancomycin-Resistant Enterococcus Surveillance Program. Clin. Infect. Dis. 1999, 29:573-579.
14. Huckabee C.M., Huskins W.C., Murray P.R. Predicting clearance of colonization with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus by use of weekly surveillance cultures. J. Clin. Microbiol. 2009, 47:1229-1230.
15. Lankford M.G., Collins S., Youngberg L., Rooney D.M., Warren J.R., Noskin G.A. Assessment of materials commonly utilized in health care: implications for bacterial survival and transmission. Am. J. Infect. Control 2006, 34:258-263.
16. Leclercq R., Derlot E., Duval J., Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 1988, 319:157-161.
17. Lee T.A., Hacek D.M., Stroupe K.T., Collins S.M., Peterson L.R. Three surveillance strategies for vancomycin-resistant enterococci in hospitalized patients: detection of colonization efficiency and a cost-effectiveness model. Infect. Control Hosp. Epidemiol. 2005, 26:39-46.
18. Mehta M.S., Paule S.M., Hacek D.M., Thomson R.B., Kaul K.L., Peterson L.R. Optimization of a laboratory-developed test utilizing roche analyte-specific reagents for detection of Staphylococcus aureus, methicillin-resistant S. aureus, and vancomycin-resistant Enterococcus species. J. Clin. Microbiol. 2008, 46:2377-2380.
19. Merriam-Webster Perianal sample. Merriam-Webster's Medical Dictionary 2006, Merriam -Webster, Springfield, MA.
20. Muto C.A., Jernigan J.A., Ostrowsky B.E., Richet H.M., Jarvis W.R., Boyce J.M., Farr B.M. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect. Control Hosp. Epidemiol. 2003, 24:362-386.
21. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect. Control 2004, 32:470-485.
22. Pacio G.A., Visintainer P., Maguire G., Wormser G.P., Raffalli J., Montecalvo M.A. Natural history of colonization with vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and resistant gram-negative bacilli among long-term-care facility residents. Infect. Control Hosp. Epidemiol. 2003, 24:246-250.
23. Palladino S., Kay I.D., Flexman J.P., Boehm I., Costa A.M., Lambert E.J., Christiansen K.J. Rapid detection of vanA and vanB genes directly from clinical specimens and enrichment broths by real-time multiplex PCR assay. J. Clin. Microbiol. 2003, 41:2483-2486.
24. Perencevich E.N., Fisman D.N., Lipsitch M., Harris A.D., Morris J.G., Smith D.L. Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units. Clin. Infect. Dis. 2004, 38:1108-1115.
25. Petrich A.K., Luinstra K.E., Groves D., Chernesky M.A., Mahony J.B. Direct detection of vanA and vanB genes in clinical specimens for rapid identification of vancomycin resistant enterococci (VRE) using multiplex PCR. Mol. Cell. Probes 1999, 13:275-281.
26. Reik R., Tenover F.C., Klein E., McDonald L.C. The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004. Diagn. Microbiol. Infect. Dis. 2008, 62:81-85.
27. Reyes K., Malik R., Moore C., Donabedian S., Perri M., Johnson L., Zervos M. Evaluation of risk factors for coinfection or cocolonization with vancomycin-resistant enterococcus and methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 2010, 48:628-630.
28. Salgado C.D. The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients. Am. J. Infect. Control 2008, 36:S175-S178.
29. Shadel B.N., Puzniak L.A., Gillespie K.N., Lawrence S.J., Kollef M., Mundy L.M. Surveillance for vancomycin-resistant enterococci: type, rates, costs, and implications. Infect. Control Hosp. Epidemiol. 2006, 27:1068-1075.
30. Siegle J.D., Rhinehart E., Jackson M., Chiarello L., Healthcare Infection Control Practices Advisory Committee Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007, http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdfAccessed February 15, 2011.
31. Sievert D.M., Rudrik J.T., Patel J.B., McDonald L.C., Wilkins M.J., Hageman J.C. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin. Infect. Dis. 2008, 46:668-674.
32. Sloan L.M., Uhl J.R., Vetter E.A., Schleck C.D., Harmsen W.S., Manahan J., Thompson R.L., Rosenblatt J.E., Cockerill F.R. Comparison of the Roche LightCycler vanA/vanB detection assay and culture for detection of vancomycin-resistant enterococci from perianal swabs. J. Clin. Microbiol. 2004, 42:2636-2643.
33. Stamper P.D., Cai M., Lema C., Eskey K., Carroll K.C. Comparison of the BD GeneOhm VanR assay to culture for identification of vancomycin-resistant enterococci in rectal and stool specimens. J. Clin. Microbiol. 2007, 45:3360-3365.
34. Tacconelli E., Cataldo M.A. Vancomycin-resistant enterococci (VRE): transmission and control. Int. J. Antimicrob. Agents 2008, 31:99-106.
35. Usacheva E.A., Ginocchio C.C., Morgan M., Maglanoc G., Mehta M.S., Tremblay S., Karchmer T.B., Peterson L.R. Prospective, multicenter evaluation of the BD GeneOhm VanR assay for direct, rapid detection of vancomycin-resistant Enterococcus species in perianal and rectal specimens. Am. J. Clin. Pathol. 2010, 134:219-226.
36. Vidal M., Forestier C., Charbonnel N., Henard S., Rabaud C., Lesens O. Probiotics and intestinal colonization by vancomycin resistant enterococci in mice and humans. J. Clin. Microbiol. 2010, 48:2595-2598.
37. Weber S.G., Huang S.S., Oriola S., Huskins W.C., Noskin G.A., Harriman K., Olmsted R.N., Bonten M., Lundstrom T., Climo M.W., Roghmann M.C., Murphy C.L., Karchmer T.B. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Infect. Control Hosp. Epidemiol. 2007, 28:249-260.
38. Wendt C., Wiesenthal B., Dietz E., Ruden H. Survival of vancomycin-resistant and vancomycin-susceptible enterococci on dry surfaces. J. Clin. Microbiol. 1998, 36:3734-3736.
39. Werner G., Coque T.M., Hammerum A.M., Hope R., Hryniewicz W., Johnson A., Klare I., Kristinsson K.G., Leclercq R., Lester C.H., Lillie M., Novais C., Olsson-Liljequist B., Peixe L.V., Sadowy E., Simonsen G.S., Top J., Vuopio-Varkila J., Willems R.J., Witte W., Woodford N. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill. 2008, 13. pii:19046.
40. Westgard J.O., Seehafer J.J., Barry P.L. Allowable imprecision for laboratory tests based on clinical and analytical test outcome criteria. Clin. Chem. 1994, 40:1909-1914.
41. Wilson E.B. Probable inference, the law of succession, and statistical inference. J. Am. Stat. Assoc. 1927, 22:209-212.
42. Wolk D.M., Picton E., Johnson D., Davis T., Pancholi P., Ginocchio C.C., Finegold S., Welch D.F., de Boer M., Fuller D., Solomon M.C., Rogers B., Mehta M.S., Peterson L.R. Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J. Clin. Microbiol. 2009, 47:758-764.
43. Wolk D.M., Struelens M.J., Pancholi P., Davis T., Della-Latta P., Fuller D., Picton E., Dickenson R., Denis O., Johnson D., Chapin K. Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA/SA skin and soft tissue and blood culture assays. J. Clin. Microbiol. 2009, 47:823-826.
44. Zhanel G.G., DeCorby M., Laing N., Weshnoweski B., Vashisht R., Tailor F., Nichol K.A., Wierzbowski A., Baudry P.J., Karlowsky J.A., Lagace-Wiens P., Walkty A., McCracken M., Mulvey M.R., Johnson J., Hoban D.J. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob. Agents Chemother. 2008, 52:1430-1437.